AVN MRI Grades Explained: What Grade 1, 2, 3, and 4 Actually Mean for Your Hip

AVN is a progressive condition — the bone does not stay at Grade 2 if the blood supply remains cut off. It moves toward collapse. The grade on your MRI tells you exactly where you are on that progression, and it directly determines which treatments are realistic versus wishful thinking.

There are two grading systems in common use in India:

ARCO (Association Research Circulation Osseous) staging — the most internationally recognised and what most MRI reports use. Stages 1 through 4.

Ficat-Arlet staging — an older system still used by some surgeons in India. Also 4 stages, slightly different definitions.

This guide uses ARCO staging throughout, which is what the majority of Indian radiology reports now use. If your report says Ficat Stage 2, it broadly corresponds to ARCO Stage 2 — the clinical implications are similar.

The critical concept: AVN grades are not interchangeable. A patient with Grade 1 and a patient with Grade 3 have the same disease name but entirely different prognoses and treatment options. Treating them identically is wrong.

What the MRI shows: abnormal signal in the femoral head (the ball of the hip joint) without visible bone changes on the X-ray. The bone architecture is intact. There may be bone marrow oedema — a sign that the bone is under stress and blood supply is compromised, but the bone itself has not begun to die structurally.

What this means clinically: Grade 1 is the earliest detectable stage. Many Grade 1 patients have no pain or only mild hip discomfort — the MRI was done for another reason, or because of a high-risk history (steroid use, alcohol, sickle cell, COVID-related steroids). This is the stage where the window for non-surgical intervention is widest.

Can Grade 1 be treated without surgery? Yes — this is the stage where non-surgical treatment has the strongest evidence. The goals are: stop the progression by addressing the cause (stopping steroids if still in use, treating the underlying condition), improving circulation to the femoral head, and protecting the joint from excessive loading during recovery. Documented improvement and stabilisation at Grade 1 is achievable.

The risk at Grade 1: because symptoms may be mild, patients sometimes wait. Grade 1 can progress to Grade 2 within months if the cause is not addressed. Early diagnosis is only valuable if it is followed by early action.

Who tends to be at Grade 1: patients who had COVID-related steroid use and got an early screening MRI, or those with a family history of AVN who got checked proactively. This is not the common presentation — most patients present at Grade 2 or 3 with pain.

What the MRI shows: visible sclerosis (increased bone density) or cyst formation in the femoral head, but the spherical shape of the femoral head is still intact. No crescent sign (the thin black line indicating subchondral fracture). No collapse of the bone surface. X-ray may now show changes, unlike Grade 1.

What this means clinically: Grade 2 is where the majority of patients seek help. The pain is significant — typically in the groin or anterior hip, worsening with weight bearing and at night. The femoral head is compromised but has not yet fractured at the subchondral level.

Can Grade 2 be treated without surgery? Yes — and this is where the majority of our documented cases fall. The femoral head architecture is still intact, which means the joint can recover if the blood supply is restored and loading is managed appropriately. The treatment window is meaningful but narrowing compared to Grade 1. The urgency is higher — Grade 2 can progress to Grade 3 within 6-18 months without treatment.

The size of the lesion matters within Grade 2: a small lesion (less than 15-20% of the femoral head) has a significantly better prognosis than a large one (more than 30-40%). Your MRI report should mention lesion size or extent — if it does not, ask your radiologist. Large Grade 2 lesions are at higher risk of progression and require more aggressive conservative management.

What to avoid at Grade 2: prolonged weight bearing without support, high-impact activities (running, heavy lifting), any further steroid use, smoking, and alcohol. These are not lifestyle suggestions — they are structural protection measures.

What the MRI shows: the crescent sign — a thin line of subchondral bone fracture visible on MRI or X-ray. This means the outer shell of the femoral head has begun to separate from the dying bone beneath it. The spherical shape may still appear mostly intact on MRI, but the structural integrity is compromised.

What this means clinically: Grade 3 is the most contested stage in AVN management. This is where reasonable doctors disagree about the right path, and where the honest answer is more complex than a simple yes or no to surgery.

Grade 3 — the honest breakdown:

Grade 3A (early, small lesion, no visible depression): The crescent sign is present but the bone surface has not yet visibly collapsed. The femoral head still appears round on X-ray. With strict weight protection (crutches or walker, strict activity restriction), some Grade 3A cases stabilise. This is uncommon but documented. It requires complete commitment to non-weight-bearing protocols — not partial reduction in activity.

Grade 3B (collapse beginning to show): The femoral head is visibly flattening on X-ray. The cartilage above the dead bone is under increasing stress. At this point, the biological case for non-surgical recovery is significantly weaker. Collapse, once visible on X-ray, rarely reverses — the dead bone does not rebuild itself.

The honest statement about Grade 3: if your MRI shows Grade 3 with visible flattening, the surgeon recommending hip replacement is not wrong. The question is whether you have Grade 3A or 3B, and how quickly the collapse is progressing. This requires a second opinion from an experienced orthopaedic surgeon who reviews sequential imaging, not just a single scan.

What conservative treatment aims for at Grade 3A: not reversal of the crescent sign, but preventing further collapse and maintaining the hip long enough that the patient can delay surgery, or in some cases avoid it. This is a realistic but limited goal — it requires honest expectation-setting.

What the MRI shows: the femoral head has collapsed. The spherical shape is gone — the bone has caved in, and the cartilage above it has been damaged. The acetabulum (the socket) may also show degenerative changes. Secondary osteoarthritis has set in.

What this means clinically: Grade 4 is structural failure of the hip joint. The dead bone cannot rebuild. The collapsed femoral head cannot regain its shape. This is the stage where hip replacement becomes the most appropriate recommendation for most patients.

The honest answer about Grade 4: non-surgical treatment for Grade 4 AVN does not reverse the structural damage. The femoral head has collapsed — that is a mechanical fact. Pain management, reduced loading, and supportive care can make Grade 4 more livable, but they do not restore the hip.

Who benefits from hip replacement at Grade 4: patients with significant pain affecting quality of life, inability to walk reasonable distances, and reduced functional independence. Modern hip replacement has excellent outcomes — 15-20 year implant survival rates with current implants, full pain resolution in the majority of cases, return to active life within 3-6 months.

Who might delay hip replacement at Grade 4: very young patients (under 30-35) who wish to delay the procedure to extend the working life of the implant. In these cases, pain management and activity modification are the tools — not reversal. This is a valid choice but requires honest understanding that the structural damage is permanent.

The sentence that must be said clearly: if your MRI shows Grade 4 AVN with visible femoral head collapse, a doctor promising reversal or cure without surgery is not being honest with you. Seek a second orthopaedic opinion at a good hospital, understand the implant options, and make an informed decision about timing.

AVN is not a static condition — it either stabilises (with intervention) or progresses. Knowing how to monitor this is essential.

The monitoring schedule: repeat MRI at 6 months after starting treatment is the standard for Grade 1-2. If the MRI shows no new collapse, no increase in lesion size, and reduction in bone marrow oedema — the treatment is working. If the lesion has grown or the crescent sign has appeared — escalation of the management plan is needed.

What you are looking for on repeat imaging:

What to tell your radiologist: when ordering a repeat MRI, ask specifically for comparison with the previous study. The report should note any change in lesion volume and the status of the subchondral plate. If your radiologist cannot make this comparison because the previous films are not available, obtain a copy of your previous MRI on CD and bring it.

The importance of sequential imaging: a single MRI tells you where you are. Two MRIs 6 months apart tell you which direction you are moving — and that direction is the most important clinical information in AVN management.